CICLETANIDE IMPROVES OUTCOME AFTER LEFT CIRCUMFLEX CORONARY-ARTERY OCCLUSION-REPERFUSION IN THE DOG

被引：32

作者：

JOUVE, R

LANGLET, F

PUDDU, PE

ROLLAND, PH

GUILLEN, JC

CANO, JP

SERRADIMIGNI, A

机构：

[1] INSERM, U278, FAC PHARM, BD JEAN MOULIN, F-13385 MARSEILLE 5, FRANCE

[2] UNIV AIX MARSEILLE 2, SCH PHARM, DEPT PHARMACOL & CLIN TRIALS, F-13007 MARSEILLE, FRANCE

[3] UNIV AIX MARSEILLE 2, SCH MED, DEPT SURG RES, F-13007 MARSEILLE, FRANCE

[4] UNIV ROME LA SAPIENZA, SCH MED, DEPT CARDIOL 2, ROME, ITALY

来源：

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1986年 / 8卷 / 01期

关键词：

D O I：

10.1097/00005344-198601000-00030

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：208 / 215

页数：8

共 39 条

[1] THE EFFECT OF THE LEVEL OF THE LIGATURE ON MORTALITY FOLLOWING LIGATION OF THE CIRCUMFLEX CORONARY ARTERY IN THE DOG [J].

ALLEN, JB ;

LAADT, JR .

AMERICAN HEART JOURNAL, 1950, 39 (02) :273-278

[2] ROLE OF PROSTACYCLIN IN THE PRESERVATION OF ISCHEMIC MYOCARDIAL TISSUE IN THE PERFUSED CAT HEART [J].

ARAKI, H ;

LEFER, AM .

CIRCULATION RESEARCH, 1980, 47 (05) :757-763

[3] ACTIONS OF PROSTAGLANDIN-I2 AND PROSTAGLANDIN-E2 ON ARRHYTHMIAS PRODUCED BY CORONARY-OCCLUSION IN THE RAT AND DOG [J].

AU, TLS ;

COLLINS, GA ;

HARVIE, CJ ;

WALKER, MJA .

PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1979, 18 (05) :707-720

[4]

BADE V, 1981, CIRCULATION, V64, P274

[5]

BENEDETTI J, 1983, STATISTICAL SOFTWARE, P557

[6]

BRAQUET P, 1983, LANCET, V1, P1218

[7]

BRAQUET P, 1983, N-S ARCH PHARMACOL S, V324, P239

[8]

COCKER SJ, 1981, EARLY ARRHYTHMIAS RE, P93

[9] INCREASED R-WAVE AMPLITUDE INDUCED BY ACUTE MYOCARDIAL ISCHEMIA IN THE DOG - A PREDICTOR OF MALIGNANT VENTRICULAR ARRHYTHMIAS [J].

DAVID, D ;

MICHELSON, EL ;

NAITO, M ;

SCHAFFENBURG, M ;

DREIFUS, LS .

AMERICAN JOURNAL OF CARDIOLOGY, 1982, 50 (04) :844-848

[10] ACTIVATION OF PROSTACYCLIN SYNTHESIS IN CULTURED AORTIC SMOOTH-MUSCLE CELLS BY DIURETIC ANTIHYPERTENSIVE DRUGS [J].

DORIAN, B ;

LARRUE, J ;

DEFEUDIS, FV ;

SALARI, H ;

BORGEAT, P ;

BRAQUET, P .

BIOCHEMICAL PHARMACOLOGY, 1984, 33 (14) :2265-2269

← 1 2 3 4 →